Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer

Lung cancer is the leading cause of cancer-related mortality worldwide. The discovery of tyrosine kinase inhibitors effectively targeting EGFR mutations in lung cancer patients in 2004 represented the beginning of the precision medicine era for this refractory disease. This great progress benefits f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zixi, Xing, Yurou, Li, Bingjie, Li, Xiaoyu, Liu, Bin, Wang, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743956/
https://www.ncbi.nlm.nih.gov/pubmed/36508072
http://dx.doi.org/10.1186/s43556-022-00107-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743956/
https://www.ncbi.nlm.nih.gov/pubmed/36508072
http://dx.doi.org/10.1186/s43556-022-00107-x

Ejemplares similares